Motif ID: Ikzf2
Z-value: 1.136

Transcription factors associated with Ikzf2:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Ikzf2 | ENSMUSG00000025997.7 | Ikzf2 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Ikzf2 | mm10_v2_chr1_-_69685937_69685966 | 0.21 | 4.8e-01 | Click! |
Top targets:
Showing 1 to 20 of 97 entries
Gene overrepresentation in biological_process category:
Showing 1 to 20 of 44 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 7.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.6 | 2.9 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 | 2.1 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.2 | 1.9 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.6 | 1.7 | GO:0021893 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
0.0 | 1.4 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.1 | 1.3 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.4 | 1.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 1.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 1.2 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 1.1 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.2 | 1.0 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.0 | 1.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.3 | 0.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.2 | 0.9 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) positive regulation of blood vessel remodeling(GO:2000504) |
0.2 | 0.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.8 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 0.6 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.0 | 0.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.3 | 0.5 | GO:0060838 | lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
Gene overrepresentation in cellular_component category:
Showing 1 to 16 of 16 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 2.9 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 2.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 2.0 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.4 | 1.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.4 | 1.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 1.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 1.0 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.7 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.4 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.2 | GO:0034679 | integrin alpha2-beta1 complex(GO:0034666) integrin alpha3-beta1 complex(GO:0034667) integrin alpha9-beta1 complex(GO:0034679) |
0.0 | 0.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 0.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.2 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
Gene overrepresentation in molecular_function category:
Showing 1 to 20 of 28 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 7.4 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 3.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 2.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 2.1 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 2.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 1.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 1.3 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 1.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 1.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.0 | 0.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.7 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.0 | 0.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.5 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.5 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |